Neurochemical studies of Alzheimer's disease

Neurodegeneration

Volumn 5, Issue 4, 1996, Pages 381-391

  Palmer, Alan M ^a  

^a Cerebrus Limited   (United Kingdom)

Author keywords

Dementia; Human brain; Pathology; Pharmacotherapy; Transmitter

Indexed keywords

4 AMINOBUTYRIC ACID RECEPTOR;

ALZHEIMER DISEASE; BRAIN CORTEX; CHOLINERGIC NERVE CELL; CONFERENCE PAPER; DISEASE COURSE; DOPAMINERGIC NERVE CELL; HUMAN; INTERNEURON; NERVE CELL; NEUROCHEMISTRY; NORADRENERGIC NERVE; PERIKARYON; PRIORITY JOURNAL; PYRAMIDAL NERVE CELL; SEROTONINERGIC NERVE CELL; SYMPTOMATOLOGY;

EID: 0030483709     PISSN: 10558330     EISSN: None     Source Type: Journal    
DOI: 10.1006/neur.1996.0051     Document Type: Conference Paper

References (83)

1. Arendt T, Bigl, Arendt A, Tennstedt A (1983) Loss of neurones in the nuclear basalis of Meynert in Alzheimer's disease, paralysis agitans and Korsakoff's Disease. Acta Neuropathol G1:101-108
2. Beal MF, Mazurek MF, Svendsen CN, Bird ED, Martin JB (1986) Widespread reduction of somatostatin-like immunoreactivity in the cerebral cortex in Alzheimer's disease. Annals Neurol 20:489-495
3. Behl C, Davis J, Cole GM, Schubert D (1992) Vitamin E protects nerve cells from amyloid β protein toxicity. Biochem Biophys Res Commun 186:944-950
4. Bernheimer H, Birkmayer W, Hornykiewicz O, Jellinger K, Seitelberger F (1973) Brain dopamine and the syndromes of Parkinson and Huntington. J Neurol Sci 20:415-455
5. Bird ED, Iversen LL (1974) Huntington's chorea: post-mortem measurement of glutamic acid decarboxylase, choline acetyltransferase and dopamine in the basal ganglia. Brain 97:457-472
6. Bowen DM (1977) Biochemistry of dementias. Proc Roy Soc Med 70:351-352
7. Bowen DM, Smith CB, White P, Davison AN (1976) Neurotransmitter-related enzymes and indices of hypoxia in senile dementia and other abiotrophies. Brain 99:459-496
8. Bowen DM, Smith CB, White P, Goodhardt MJ, Spillane JA, Flack RHA, Davison AN (1977a) Chemical pathology of the organic dementias I. Validity of biochemical measurements on human post-mortem brain specimens. Brain 100:397-426
9. Bowen DM, Smith CB, White P, Flack RHA, Carrasco LH, Gedye JL, Davison AN (1977b) Chemical pathology of the organic dementias II. Quantitative estimation of cellular changes in post-mortem brains. Brain 100:427-453
10. Bowen DM, Sims NR, Lee KAP, Marek KL (1982a) Acetylcholine synthesis and glucose oxidation are preserved in human brain obtained shortly after death. Neurosci Lett 31:195-199
11. Bowen DM, Benton JS, Spillane JA, Smith CCT, Allen SJ (1982b) Choline acetyltransferase activity and histopathology of frontal neocortex from biopsies of demented patients. J Neurol Sci 57:191-202
12. Breitner JCS, Gau MSW, Welsh KA, Plassman BL, McDonald WM, Helms MJ, Anthony JC (1994) Inverse association if anti-inflammatory treatments and Alzheimer's disease: initial results of a co-twin control study. Neurology 44:227-232
13. Chen CPL-H, Alder JT, Bowen DM, Esiri MM, McDonald B, Hope T, Jobst KA, Francis PT (1996) Presynaptic serotonergic markers in community-acquired cases of Alzheimer's disease with depression and neuroleptic treatment. J Neurochem 66:1592-1598
14. Crapper McLachlan DR, Dalton AJ, Kruck TPA, Bell MY, Smith WL, Kalow W, Andrews DF (1991) Intramuscular desferrioxamine in patients with Alzheimer's disease. Lancet 337:1304-1308
15. Cross AJ, Crow TJ, Johnson JA, Joseph MH, Perry EK, Perry RH, Blessed G, Tomlinson BE (1983) Monoamine metabolism in senile dementia of Alzheimer type. J Neurol Sci 60:383-392
16. Curcio CA, Kemper T (1984) Nucleus raphe dorsalis in dementia of the Alzheimer type: Neurofibrillary changes and neuronal packing density. J Neuropathol Exp Neurol 43:359-368
17. D'Amato RJ, Zweig RM, Whitehouse PH, Wenk GC, Singer HS, Mayeux R, Price KL, Snyder SH (1987) Aminergic systems in Alzheimer's disease and Parkinson's disease. Ann Neurol 22:229-236
18. Davies P, Maloney AJP (1976) Selective loss of central cholinergic neurones in Alzheimer's disease. Lancet ii:1403
19. Davies P, Katzman R, Terry RD (1980) Reduced somatostatin-like immunoreactivity in cerebral cortex from cases of Alzheimer disease and Alzheimer senile dementia. Nature 288:279-280
20. Dodd PR, Hambley JW, Cowburn RF, Hardy JA (1988) A comparison of methodologies for the study of functional transmitter neurochemistry in human brain. J Neurochem 50:1333-1345
21. Duffy PE, Rapport M, Graf L (1980) Glial fibrillary acidic protein and Alzheimer type senile dementia. Neurology 30:778-782
22. Ehringer H, Hornykiewicz O (1960) Verteilung von Noradrenalin und Dopamin (3-Hydroxytyramine) im Gehirn des Menschen und ihr Verhalten bei Erkrankungen des extrapyramidalen Systems. Klin Wshcr 38:1236-1239
23. Eikelenboom P, Zhan S-S, Van Gool WA, Allsop D (1994) Inflammatory mechanisms in Alzheimer's disease Trends Neurosci 15:447-450
24. Ellison DW, Beal MF, Mazurek MF, Bird ED, Martin JB (1986) A post-mortem study of amino acid neurotransmitters in Alzheimer's disease. Ann Neurol 20:616-621
25. Evans DA, Harris Funkenstein H, Albert MS, Scherr PA, Cook NR, Chown MJ, Hebert LE, Hennekens CH, Taylor JO (1989) Prevalence of Alzheimer's disease in a community population of older persons - higher than previously reported. J Am Med Assoc 262:2551-2556
26. Francis PT, Bowen DM, Lowe SL, Neary D, Mann DMA, Snowden JS (1987) Somatostatin content and release measured in cerebral biopsies from demented patients. J Neurol Sci 78:1-16
27. Francis PT, Palmer AM, Sims NR, Bowen DM, Davison AN, Esiri MM, Neary D, Snowden JS, Wilcock GK (1985) Neurochemical studies of early-onset Alzheimer's disease: Possible influence on treatment. N Engl J Med 313:7-11
28. Games D, Adams D, Alessandini R, Barbour R, Bethelotte P, Blackwell C, Carr T, Clemens J, Donaldson T, Gillespie F, Guido T, Hagopian S, Johnson-Wood K, Khan K, Lee M, Leibowitz P, Lieberburg I, Little S, Masliah E, McConlogue L, Montoya-Zavala M, Mucke L, Paganini L, Penniman E, Power M, Schenk D, Seubert P, Snyder B, Soriano F, Tan H, Vitale J, Wadsworth S, Wolozin B, Zhao J (1995) Alzheimer-type neuropathology in transgenic mice overexpressing V717F beta-amyloid precursor protein. Nature 373:523-527
29. Gottfries C-G, Adolfsson R, Aquilonius S-M, Carlsson A, Eckernäs S-A, Nordberg A, Oreland L, Svennerholm L, Wiberg A, Winblad B (1983) Biochemical changes in dementia disorders of Alzheimer type (AD/SDAT). Neurobiol Aging 4:261-271
30. Greenamyre JT, Maragos WF (1993) Neurotransmitter receptors in Alzheimer disease. Cerebrovasc Brain Metab Rev 5:61-94
31. Hajimohammadreza I, Brammer M (1990) Brain membrane fluidity and lipid peroxidation in Alzheimer's disease. Neurosci Lett 112:333-337
32. Hardy J, Allsop D (1991) Amyloid deposition as the central event in the aetiology of Alzheimer's disease. Trends Neurosci 12:383-385
33. Hardy J, Cowburn R, Barton A, Reynolds G, Lofdahl E, O'Carroll A-M, Wester P, Winblad B (1987) Region-specific loss of glutamate innervation in Alzheimer's disease. Neurosci Lett 73:77-80
34. Harrison PJ, Procter AW, Barton AJL, Lowe SL, Najlerahim A, Bertolucci PHF, Bowen DM, Pearson RCA (1991) Terminal coma affects messenger RNA detection in post mortem human temporal cortex. Mol Brain Res 9:161-164
35. Hsiao KK, Borchelt DR, Olson K, Johannsdottir R, Kitt C, Yunis W, Xu S, Eckman C, Younkin S, Price D, Iadecola C, Clark HB, Carison G (1995) Age-related CNS disorder and early death in transgenic FVB/N mice overexpressing Alzheimer amyloid proteins. Neuron 15:1203-1218
36. Hyman BT, Van Hoesen GW, Damasio AR (1987) Alzheimer's disease: Glutamate depletion in the hippocampal perforant pathway zone. Ann Neurol 22:37-40
37. Kanner BI (1997). Structure, function and regulation of sodium-coupled neurotransmitter transport. In Turner AJ, Stephenson FA (eds) Amino Acid Neurotransmission. Portland Press, London, in press
38. Korey SR, Scheinberg L, Terry R, Stein A (1963) Studies in presenile dementia. Trans Am Neurol Assoc 86:99-102
39. Lowe SL, Francis PT, Procter AW, Palmer AM, Davison AN, Bowen DM (1988) Gamma aminobutyric acid concentration in brain tissue at two stages of Alzheimer's disease. Brain 111:785-799
40. Mann DMA, Marcyniuk B, Yates PO, Neary D, Snowden JS (1988) The progression of the pathological changes of Alzheimer's disease in frontal and temporal neocortex examined both at biopsy and at autopsy. Neuropathol Appl Neurobiol 14:177-195
41. Mann DMA, Yates PO, Marcyniuk B (1984) Monoaminergic neurotransmitter systems in presenile Alzheimer's disease and in senile dementia of Alzheimer type. Clin Neuropathol 3:199-205
42. Marcyniuk B, Mann DMA, Yates PO (1986) Loss of nerve cells from the locus ceruleus in Alzheimer's disease is topographically arranged. Neurosci Lett 64:247-252
43. McGeer PL, McGeer EG (1976) Enzymes associated with the metabolism of catecholamines, acetylcholine and GABA in human controls and patients with Parkinson's disease and Huntington's chorea. J Neurochem 26:65-76
44. McGeer PL, McGeer EG, Wada JA (1971) Glutamic acid decarboxylase in Parkinson's disease and epilepsy. Neurology 21:1000-1007
45. Neary D, Snowden JS, Bowen DM, Sims NR, Mann DMA, Yates PO, Davison AN (1986a) Cerebral biopsy in the investigation of presenile dementia due to cerebral atrophy. Journal of Neurol Neurosurg Psychiat 49:157-162
46. Neary D, Snowden JS, Mann DMA, Bowen DM, Sims NR, Northen B, Yates PO, Davison AN (1986b) Alzheimer's disease: A correlative study. J Neurol Neurosurg Psychiat 49:229-237
47. 3H]-acetylcholine efflux from Alzheimer brain slices to normal level. J Neural Transm 67:275-285
48. Palmer AM, Sims NR, Bowen DM, Neary D, Palo J, Wikstrom J, Davison AN (1984) Monamine metabolite concentrations in lumbar cerebrospinal fluid of patients with histologically verified Alzheimer's dementia. J Neurol Neurosurg Psychiat 47:481-484
49. Palmer AM, Bowen DM (1985) 5-Hydroxyindoleacetic acid and homovanillic acid in the cerebrospinal fluid and caudate nucleus of histologically verified examples of Alzheimer's disease. Biochem Soc Trans 13:167-168
50. Palmer AM, Procter AW, Stratmann GC, Bowen DM (1986) Excitatory amino acid-releasing and cholinergic neurons in Alzheimer's disease. Neurosci Lett 66:199-204
51. Palmer AM, Francis PT, Benton JS, Sims NR, Mann DMA, Neary D, Snowden JS, Bowen DM (1987a) Presynaptic serotonergic dysfunction in patients with Alzheimer's disease. J Neurochem 48:8-15
52. Palmer AM, Francis PT, Bowen DM, Benton JS, Neary D, Mann DMA, Snowden SJ (1987b) Catecholaminergic neurones assessed ante-mortem in Alzheimer's disease. Brain Res 414:365-375
53. Palmer AM, Wilcock GK, Esiri MM, Francis PT, Bowen DM (1987c) Monoaminergic innervation of the frontal and temporal lobes in Alzheimer's disease. Brain Res 401:231-238
54. Palmer AM, Lowe SL, Frances PT, Bowen DM (1988a) Are post-mortem biochemical studies of human brain worthwhile? Biochem Soc Trans 16:472-475
55. Palmer AM, Stratmann GC, Procter AW, Bowen DM (1988b) Possible neurotransmitter basis of behavioural changes in Alzheimer's disease. Ann Neurol 23:616-620
56. Palmer AM, Gershon S (1990) Is the neurochemical basis of Alzheimer's disease cholinergic or glutamatergic? FASEB Journal, 4:2745-2752.
57. Palmer AM, DeKosky ST (1993) Monoamine neurons in aging and Alzheimer's disease. J. Neural Transm 91:135-159.
58. Palmer AM, Burns MA (1994a) Preservation of the polyamine, redox and glycine modulatory domains of the N-methyl-D-aspartate receptor in Alzheimer's disease. J Neurochem 62:187-196.
59. Palmer AM, Burns MA (1994b) Selective increase in lipid peroxidation in the inferior temporal cortex in Alzheimer's disease. Brain Res 645:338-342
60. 3H]aspartate and endogenous L-aspartate and L-glutamate from rat cerebral cortex. Neurochem Int 25:441-450
61. Palmer AM, Robichaud PJ and Reiter CT (1994) The release and uptake of excitatory amino acids in rat brain: Effect of aging and oxidative stress. Neurobiol Aging 15:103-111.
62. Pearce BR, Palmer AM, Bowen DM, Wilcock GK, Esiri MM, Davison AN (1984) Neurotransmitter dysfunction and atrophy of the caudate nucleus in Alzheimer's disease. Neurochem Pathol 2:221-232
63. Pearson RCA, Esiri MM, Hiorns RW, Wilcock GK, Powell TPS (1985) Anatomical correlates of the distribution of the pathological changes in the neocortex in Alzheimer's disease. Proc Natl Acad Sci USA 82:1-4
64. Perry EK, Perry RH, Blessed G, Tomlinson BE (1977) Necropsy evidence of central cholinergic deficits in senile dementia. Lancet i:187
65. Perry EK, Tomlinson BE, Blessed G, Perry RH, Cross AJ, Crow TT (1981) Noradrenergic and cholinergic systems in senile dementia of Alzheimer type. Lancet 2:149
66. Pope A, Hess HH, Lewin E (1964) Studies on the microchemical pathology of human cerebral cortex. In Choen MM, Snider RS (eds), Morphological and Biochemical correlates of Neural Activity pp 98-111
67. Procter AW, Palmer AM, Francis PT, Lowe SL, Neary D, Murphy E, Doshi R, Bowen DM (1988a) Evidence of glutamatergic denervation and possible abnormal metabolism in Alzheimer's disease. J Neurochem 50:790-801
68. Procter AW, Lowe SL, Palmer AM, Francis PT, Esiri MM, Stratmann GC, Najlerahim A, Patel AJ, Hunt A, Bowen DM (1988b) Topographical distribution of neurochemical changes in Alzheimer's disease. J Neurol Sci 84:125-140
69. Procter AW, Stratmann GC, Francis PT, Lowe SL, Bertolucci PHF, Bowen DM (1991) Characterisation of the glycine modulatory site of the N-methyl-D-aspartate receptor-ionophore complex in human brain. J Neurochem 56:299-310
70. Reinikainen KJ, Paljarvi L, Huuskonen M, Soininen H, Laakso M, Riekkinen PJ (1988) A post mortem study of noradrenergic, serotonergic and GABAergic neurons in Alzheimer's disease. J Neurol Sci 84:101-116
71. Rogers J, Morrison JH (1985) Quantitative morphology and regional laminar distributions of senile plaques in Alzheimer's disease. Neuroscience 5:2801-2808
72. Rylett RJ, Ball MJ, Colhoun EH (1983) Evidence for high affinity choline transport in synaptosomes prepared from hippocampus of patients with Alzheimer's disease. Brain Res 289:169-175
73. Sims NR, Bowen DM, Allen ST, Smith CCT, Neary D, Thomas DJ, Davison AN (1983) Presynaptic cholinergic dysfunction in patients with dementia. J Neurochem 40:503-509
74. Sinet P-M, Ceballos-Picot I (1992) Free Radicals in the Brain. Springer-Verlag, New York, pp 91-98
75. Smith CCT, Bowen DM, Davison AN (1983) The evoked release of endogenous amino acids from tissue prisms of human neocortex. Brain Res 269:103-109
76. Smith CD, Carney JM, Starke-Reed PE, Oliver CN, Stradman ER, Floyd RA and Markesbery WR (1991) Excess brain protein oxidation and enzyme dysfunction in normal aging and Alzheimer's disease. Proc Natl Acad Sci USA 88:10540-10543
77. Spillane JA, White P, Goodhart MJ, Flack RHA, Bowen DM, Davison AN (1977) Selective vulnerability of neurones in organic dementia. Nature 266:558-559
78. Spokes EGS (1979) An analysis of factors influencing measurements of dopamine, noradrenaline, glutamate decarboxylase and choline acetylase in human post-mortem brain tissue. Brain 102:333-346
79. Subbarao KV, Richardson JS, Ang LC (1990) Autopsy samples of Alzheimer's cortex show increased peroxidation in vitro. J Neurochem 55:342-345
80. Volicer L, Crino PB (1990) Involvement of free radicals in dementia of the Alzheimer type: A hypothesis. Neurobiol Aging 11:567-571
81. Whitehouse PH, Price DL, Strable RG, Clark AW, Coyle JT, Delong R (1982) Alzheimer's disease and senile dementia: Loss of neurons in the basal forebrain. Science 215:1237-1239
82. Zubenko GS, Moossy J (1988) Major depression in primary dementia: Clinical and neuropathologic correlates. Arch Neurol 45:1182-1186
83. Zweig RM, Ross CA, Hedreen JC, Steele C, Cardillo JE, Whitehouse PJ, Folstein MF, Price DL (1988) The neuropathology of aminergic nuclei in Alzheimer's disease. Ann Neurol 24:233-242